Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
AEON

Updated 10/6/2026, 5:33 PM ET.

AEON

AEON Biopharma, Inc.

Buy$243,455

LYNCH TIMOTHY P

10% owner

1,150,000 shat $0.21Filed Aug 21, 7:41 PM ETFiling

Read from public SEC filings. Not financial advice.